|
Safety of trifluridine/tipiracil (FTD/TPI) in elderly patients with metastatic colorectal cancer. |
|
|
Honoraria - Taiho Pharmaceutical |
Consulting or Advisory Role - CASI Pharmaceuticals |
|
|
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Sirtex Medical |
|
|
Consulting or Advisory Role - Amgen; Bayer; Celgene; Genentech; Taiho Pharmaceutical |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Multiple pharmaceutical/biotech companies |
|
|
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Sanofi (Inst) |
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Sanofi (Inst) |
Travel, Accommodations, Expenses - Amgen; Bayer; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche |